Clinical Trial Update: Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. [Phase 3]

View source ↗

Summary

This report describes a Phase 3 clinical trial evaluating the efficacy and safety of Berlim 25/20 for dyslipidemia associated with type 2 diabetes mellitus, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia Associated with Type Diabetes Mellitus

Drugs mentioned

• Berlim 25/20

Snippet

Sponsor: EMS | Conditions: Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 3 | Status: RECRUITING